Suntrust Banks’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $18.8M | Sell |
351,796
-5,306
| -1% | -$273K | 0.1% | 169 |
|
|
2019
Q2 | $17.9M | Sell |
357,102
-5,851
| -2% | -$294K | 0.09% | 169 |
|
|
2019
Q1 | $19M | Buy |
362,953
+40,243
| +12% | +$2.01M | 0.1% | 163 |
|
|
2018
Q4 | $15.4M | Sell |
322,710
-39,884
| -11% | -$1.96M | 0.09% | 174 |
|
|
2018
Q3 | $18.2M | Sell |
362,594
-12,888
| -3% | -$655K | 0.09% | 173 |
|
|
2018
Q2 | $18.9M | Sell |
375,482
-2,608
| -0.7% | -$131K | 0.1% | 163 |
|
|
2018
Q1 | $18.5M | Buy |
378,090
+88,071
| +30% | +$4.1M | 0.1% | 164 |
|
|
2017
Q4 | $12.9M | Sell |
290,019
-130,545
| -31% | -$6.03M | 0.07% | 184 |
|
|
2017
Q3 | $21.3M | Buy |
420,564
+73,900
| +21% | +$3.75M | 0.13% | 138 |
|
|
2017
Q2 | $18.7M | Buy |
346,664
+53,594
| +18% | +$2.86M | 0.11% | 148 |
|
|
2017
Q1 | $15.4M | Buy |
293,070
+62,292
| +27% | +$3.16M | 0.1% | 161 |
|
|
2016
Q4 | $11.1M | Sell |
230,778
-169,708
| -42% | -$8.38M | 0.07% | 198 |
|
|
2016
Q3 | $21.6M | Sell |
400,486
-44,384
| -10% | -$2.43M | 0.13% | 133 |
|
|
2016
Q2 | $24.1M | Buy |
444,870
+34,806
| +8% | +$1.83M | 0.15% | 122 |
|
|
2016
Q1 | $20.8M | Buy |
410,064
+71,095
| +21% | +$3.54M | 0.13% | 128 |
|
|
2015
Q4 | $17.1M | Sell |
338,969
-59,784
| -15% | -$3.05M | 0.11% | 147 |
|
|
2015
Q3 | $19.2M | Sell |
398,753
-20,301
| -5% | -$1.06M | 0.13% | 127 |
|
|
2015
Q2 | $21.8M | Buy |
419,054
+71,463
| +21% | +$4.02M | 0.14% | 123 |
|
|
2015
Q1 | $20M | Buy |
347,591
+88,520
| +34% | +$5.07M | 0.13% | 133 |
|
|
2014
Q4 | $13.8M | Sell |
259,071
-25,237
| -9% | -$1.41M | 0.09% | 154 |
|
|
2014
Q3 | $16.3M | Sell |
284,308
-15,110
| -5% | -$926K | 0.11% | 142 |
|
|
2014
Q2 | $20M | Sell |
299,418
-3,584
| -1% | -$243K | 0.14% | 128 |
|
|
2014
Q1 | $20.2M | Buy |
303,002
+5,927
| +2% | +$401K | 0.07% | 285 |
|
|
2013
Q4 | $19.8M | Buy |
297,075
+28,493
| +11% | +$1.85M | 0.08% | 290 |
|
|
2013
Q3 | $16.8M | Buy |
268,582
+29,752
| +12% | +$1.92M | 0.07% | 312 |
|
|
2013
Q2 | $14.9M | Buy |
+238,830
| New | +$15.2M | 0.07% | 305 |
|
Other funds holding GSK
BCIM
